SUMMARY The incidence of antecedent events and serological evidence of preceding infection were studied in 100 patients with acute idiopathic neuropathy and age and sex matched control subjects in South-East England. Symptoms 
At least half of the reported cases of Guillain-Barre syndrome (GBS) have been preceded by infections or other antecedent events during the few weeks before the neuropathy.' A large number of events have been incriminated and in one study of 1100 case records there were 735 possible associations.2 These include a variety of different infections, vaccinations, metabolic and neoplastic conditions. The only two case controlled studies suggested a higher incidence of respiratory infections3 and gastroenteritis4 among GBS patients than in appropriate controls. Serological tests have implicated cytomegalovirus (CMV) and Epstein Barr virus (EBV) more frequently than other viruses.
Virus specific IgM antibody against CMV was detected in 33 of 220 GBS patients and against EBV in eight of 100.5 Another frequently reported association is mycoplasma; 5 of 100 patients in one study pylobacterjejuni infection was identified serologically in as many as 21 of 56 patients in an uncontrolled study .7 In that study evidence of infection with campylobacter was associated with more severe disease but mild cases of GBS asociated with the same organism have also been ported.8
Our study compares 
Results

Antecedent events
(1) Infections A history of respiratory symptoms one month before onset of the neuropathy was given by 38% of GBS patients and 12% of controls while gastrointestinal infection was reported by 17% of patients compared with 3% of controls (table 1). The peak incidence of antecedent symptoms of infection was between one and 2 weeks prior to the onset of neuropathy (fig).
(2) Immunisations The GBS patients received slightly but not significantly more immunisations in the 3 months preceding onset of neuropathy than the controls (table 2) . (3) Operations Eight patients gave a history of an operation within 3 months of the onset of neurological signs. Of these, two also had evidence of recent infection (CMV and Campylobacter jejuni). Controls could not be usefully questioned about recent operations since they were obtained from surgical wards and therefore almost all were awaiting or recovering from operations. 
Discussion
The incidence of respiratory infections among patients with GBS was first examined in a controlled prospective manner by Melnick and Flewitt.3 Two
Winer, Hughes, Anderson, Jones, Kangro, Watkins control groups were questioned making a total of 71 subjects without central or peripheral demyelinating disease. One group of 48 was taken at random from patients admitted to medical wards and a second group of 23 in which respiratory diseases were excluded was also matched for age and sex. Antecedent respiratory infections within 3 months of onset of the neuropathy were reported by 50% of GBS patients compared with 32% of controls. A significant association was present for an interval of 1 month but not 3 months before onset of GBS. Our study confirms these findings on a larger patient population and a more rigorous control group matched not only for age and sex, but also for season and geographical location. In a retrospective study Kennedy et al4 found an incidence of respiratory symptoms among GBS patients (38%) which was not significantly different from that seen in controls (27%). This may simply reflect the smaller number of patients or the fact that their data were less complete being obtained retrospectively.
None of Melnick and Flewitt's3 patients had had preceding gastrointestinal illness. However Kennedy et al4 reported gastrointestinal symptoms in 12 out of 37 GBS patients (32%) within one month of onset of neuropathic symptoms and in none of 37 controls with Bell's palsy. The controls were matched for age, sex and season. The GBS patients in our study reported a lower incidence of antecedent gastrointestinal symptoms (17%) within one month of onset of neuropathic symptoms which was nevertheless significantly higher than in controls.
Our results suggest that the greatest relative risk of developing GBS is seen in the first 2 weeks following infection. The median latency from infection to onset of neuropathic symptoms was shorter for gastrointestinal than for respiratory infections. Campylobacter was the major organism identified in association with gastrointestinal symptoms and was significantly associated with a worse outcome.
A report by Campbell'7 that six of 12 patients with GBS had had contact with feline enteritis prompted the investigation into animal contact. No association was detected. Similarly no significant association was detected between GBS and wasp or bee stings despite a report of an association of this antecedent event and GBS in some patients.'8 A few patients reported recent insect bites but not more commonly than controls. A radiculitis may follow tick bite induced borrelia infection in Bannwarth's lymphocytic meningoradiculitis or Lyme disease'9 but this was not recognised in our series.
The selection of appropriate controls for a study of this type is difficult because of the wide age range of patients and the possible role of infections in the aetiology of many comparable diseases. Kennedy et A prospective study of acute idiopathic neuropathy. II. Antecedent events al4 used controls with Bell's palsy in their study, even though viral infections may have an aetiological role in Bell's palsy itself. Ideally several sets of controls would be obtained to reduce the chance that bias within a particular control group had unduly influenced the results. Our selection of surgical controls ensured a range of controls of appropriate age who were unlikely to have immunological disease. We intended to select patients who had been admitted to surgical wards with acute cervical or lumbar radicular pain of presumed mechanical origin. Unfortunately this objective was only achieved in about one quarter of the controls, while the remainder consisted of patients admitted to hospital for elective minor surgery. Surgical patients awaiting operation may report fewer antecedent infections since they represent a population screened for fitness for anaesthetic. Minor elective operations are likely to be postponed in patients with recent significant infection. Such screening generally applies only to the week prior to anaesthesia and it seems unlikely that this bias would account for our findings.
This In the 11 patients with serological evidence of CMV infection, three reported respiratory, two reported gastrointestinal and one patient both respiratory and gastrointestinal prodromal illnesses. Virus specific IgM antibody in cases with no history of an antecedent illness is usually indicative of a primary infection but reactivation of latent CMV infection cannot be excluded.
An association of GBS with parvovirus B19 was investigated because a personal case of chronic demyelinating polyradiculoneuropathy followed documented parvovirus B19 infection-presenting as Fifth disease (a mild febrile exanthematous disease seen usually in children and now recognised to be caused by parvovirus B 19) . Although IgM antibodies to parvovirus B 19 were identified slightly more frequently in patients (4%) than controls (0%), the sera in these four cases were only weakly positive. It seems therefore unlikely that parvovirus B19 is a common antecedent infection. IgG antibodies to B19 were seen more frequently in GBS patients than controls but the significance of this finding is difficult to assess.
Our identification of only 1% to 2% of GBS patients with evidence of recent EBV infection contrasts with 8% of 100 patients in New Jersey discovered by Dowling and Cook.5 This difference may reflect variations in age between patients in the two studies. Sixty two of our patients were over 40 years and only 11 under 20 years while primary EBV infection might be expected to be more frequent among children and young adults. The ages of the patients studied by Dowling and Cook5 were not detailed and the criteria for diagnosis of infection with EBV were also different. All patients in our study were screened for antibody to EBNA. Recent primary infection was only diagnosed when IgM antibody to capsid antigen was present and antibody to EBNA absent. In addition sera that fulfilled these criteria were absorbed with heat aggregated to IgG to eliminate false positive results from IgM rheumatoid factor. Antibodies against EBNA were not sought by Dowling and Cook5 who diagnosed infection on the basis of IgM antibody after absorption.
The lack of any resemblance between the two most common antecedent agents in GBS raises interesting questions concerning the mechanism by which infection triggers the disease. Homology between myelin components and short sequences of proteins in both campylobacter and cytomegalovirus is one possibility by which T cell mediated damage ofmyelin might take place. Sequence homologies between both myelin basic protein and P2 protein and different virus proteins have been reported. 22 23 Alternatively an as yet unidentified infection might be common to all cases of GBS with other infections being coincidental. Another possibility is that infection triggers the neuropathy by interfering with suppressor cell circuits leading to a release of autoimmune phenomena. This may take place by specific mechanisms or a non specific adjuvant-like action. Such mechanisms are not mutually exclusive and the clinical syndrome of GBS may represent a common end point of a number of different pathogenetic mechanisms.
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